Skip to main content

Advertisement

Log in

A large prospective study of risk factors for adenocarcinomas and malignant carcinoid tumors of the small intestine

  • Original paper
  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

Abstract

Purpose

Small intestinal cancer is increasing in the U.S.A, yet little is known about its etiology. Our aim was to prospectively evaluate risk factors for this malignancy by the two main histologic subtypes (adenocarcinomas and carcinoids).

Methods

Hazard ratios and 95 % confidence intervals (CI) were estimated for all incident small intestinal cancers (n = 237), adenocarcinomas (n = 84), and malignant carcinoids (n = 124), by demographic and lifestyle factors among 498,376 men and women.

Results

Age was the only risk factor for adenocarcinomas (HR for ≥65 vs. 50–55 years = 3.12, 95 % CI 1.33, 7.31). Age (HR for ≥65 vs. 50–55 years = 3.31, 95 % CI 1.51, 7.28), male sex (HR = 1.44, 95 % CI 1.01, 2.05), body mass index (BMI, HR for ≥35 vs. 18.5–<25 kg/m2 = 1.95, 95 % CI 1.06, 3.58), and current menopausal hormone therapy use (HR = 1.94, 95 % CI 1.07, 3.50) were positively associated with malignant carcinoids. A family history of any cancer or colorectal cancer (HR = 1.42, 95 % CI 0.99, 2.03; 1.61, 0.97, 2.65, respectively), or a personal history of colorectal polyps (HR = 1.51, 95 % CI 0.92, 2.46) produced elevated, but not statistically significant, risks for malignant carcinoids. Race, education, diabetes, smoking, physical activity, and alcohol intake were not associated with either histologic subtype.

Conclusions

Risk factors differed according to cancer subtype; only age was associated with adenocarcinomas, whereas age, male sex, BMI, and menopausal hormone therapy use were positively associated with malignant carcinoids.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

CI:

Confidence interval

BMI:

Body mass index

HR:

Hazards ratio

References

  1. Parkin DM, Whelan SL, Ferlay J, Teppo DB (2002) Cancer Incidence in Five Continents Vol. VIII. Lyon, France: IARC Scientific Publications

  2. Ries LAG, Harkins D, Krapcho M, Mariotto A, Miller BA, Feuer EJ, Clegg L, Eisner MP, Horner MJ, Howlader N, Hayat M, Hankey BF, Edwards BK (2006) SEER Cancer Statistics Review, 1975–2003: http://seer.cancer.gov/csr/1975_2003/. Bethesda, MD: National Cancer Institute

  3. Howlader N NA, Krapcho M, Garshell J, Neyman N, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975–2010, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2010/, based on November 2012 SEER data submission, posted to the SEER web site, 2013

  4. Scelo G, Boffetta P, Hemminki K, Pukkala E, Olsen JH, Andersen A, Tracey E, Brewster DH, McBride ML, Kliewer EV, Tonita JM, Pompe-Kirn V, Chia KS, Jonasson JG, Martos C, Colin D, Brennan P (2006) Associations between small intestine cancer and other primary cancers: an international population-based study. Int J Cancer 118:189–196

    Article  PubMed  CAS  Google Scholar 

  5. Schottenfeld D, Fraumeni JF (2006) Cancer epidemiology and prevention. Oxford University Press, New York

    Book  Google Scholar 

  6. Bilimoria KY, Bentrem DJ, Wayne JD, Ko CY, Bennett CL, Talamonti MS (2009) Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Ann Surg 249:63–71

    Article  PubMed  Google Scholar 

  7. Haselkorn T, Whittemore AS, Lilienfeld DE (2005) Incidence of small bowel cancer in the United States and worldwide: geographic, temporal, and racial differences. Cancer Causes Control 16:781–787

    Article  PubMed  Google Scholar 

  8. Schottenfeld D, Beebe-Dimmer JL, Vigneau FD (2009) The epidemiology and pathogenesis of neoplasia in the small intestine. Ann Epidemiol 19:58–69

    Article  PubMed  Google Scholar 

  9. Ries LA, Young JL, Keel GE, Eisner MP, Lin YD, Horner MJ (2007) SEER survival monograph: cancer survival among adults: U.S. SEER Program, 1988–2001, patient and tumor characteristics. Bethesda, MD: National Cancer Institute

  10. Modlin IM, Champaneria MC, Chan AK, Kidd M (2007) A three-decade analysis of 3,911 small intestinal neuroendocrine tumors: the rapid pace of no progress. Am J Gastroenterol 102:1464–1473

    Article  PubMed  Google Scholar 

  11. Schatzkin A, Subar AF, Thompson FE, Harlan LC, Tangrea J, Hollenbeck AR, Hurwitz PE, Coyle L, Schussler N, Michaud DS, Freedman LS, Brown CC, Midthune D, Kipnis V (2001) Design and serendipity in establishing a large cohort with wide dietary intake distributions: the National Institutes of Health-American Association of Retired Persons Diet and Health Study. Am J Epidemiol 154:1119–1125

    Article  PubMed  CAS  Google Scholar 

  12. Michaud DS, Midthune D, Hermansen S, Leitzmann MF, Harlan LC, Kipnis V et al (2005) Comparison of cancer registry case ascertainment with SEER estimates and self-reporting in a subset of the NIH-AARP diet and health study. J Registry Manag 32:70–77

    Google Scholar 

  13. International classification of diseases for oncology: Third edition (2000). Geneva: World Health Organization

  14. Shack LG, Wood HE, Kang JY, Brewster DH, Quinn MJ, Maxwell JD, Majeed A (2006) Small intestinal cancer in England & Wales and Scotland: time trends in incidence, mortality and survival. Aliment Pharmacol Ther 23:1297–1306

    Article  PubMed  CAS  Google Scholar 

  15. Boffetta P, Hazelton WD, Chen Y, Sinha R, Inoue M, Gao YT, Koh WP, Shu XO, Grant EJ, Tsuji I, Nishino Y, You SL, Yoo KY, Yuan JM, Kim J, Tsugane S, Yang G, Wang R, Xiang YB, Ozasa K, Nagai M, Kakizaki M, Chen CJ, Park SK, Shin A, Ahsan H, Qu CX, Lee JE, Thornquist M, Rolland B, Feng Z, Zheng W, Potter JD (2012) Body mass, tobacco smoking, alcohol drinking and risk of cancer of the small intestine–a pooled analysis of over 500,000 subjects in the Asia Cohort Consortium. Ann Oncol 23:1894–1898

    Article  PubMed  CAS  Google Scholar 

  16. Cross AJ, Leitzmann MF, Subar AF, Thompson FE, Hollenbeck AR, Schatzkin A (2008) A prospective study of meat and fat intake in relation to small intestinal cancer. Cancer Res 68:9274–9279

    Article  PubMed  CAS  Google Scholar 

  17. Schatzkin A, Park Y, Leitzmann MF, Hollenbeck AR, Cross AJ (2008) Prospective study of dietary fiber, whole grain foods, and small intestinal cancer. Gastroenterology 135:1163–1167

    Article  PubMed  CAS  Google Scholar 

  18. Chen CC, Neugut AI, Rotterdam H (1994) Risk factors for adenocarcinomas and malignant carcinoids of the small intestine: preliminary findings. Cancer Epidemiol Biomarkers Prev 3:205–207

    PubMed  CAS  Google Scholar 

  19. Kaerlev L, Teglbjaerg PS, Sabroe S, Kolstad HA, Ahrens W, Eriksson M, Guenel P, Hardell L, Launoy G, Merler E, Merletti F, Stang A, Olsen J (2000) Is there an association between alcohol intake or smoking and small bowel adenocarcinoma? Results from a European multi-center case-control study. Cancer Causes Control 11:791–797

    Article  PubMed  CAS  Google Scholar 

  20. Negri E, Bosetti C, La Vecchia C, Fioretti F, Conti E, Franceschi S (1999) Risk factors for adenocarcinoma of the small intestine. Int J Cancer 82:171–174

    Article  PubMed  CAS  Google Scholar 

  21. Wu AH, Yu MC, Mack TM (1997) Smoking, alcohol use, dietary factors and risk of small intestinal adenocarcinoma. Int J Cancer 70:512–517

    Article  PubMed  CAS  Google Scholar 

  22. Hassan MM, Phan A, Li D, Dagohoy CG, Leary C, Yao JC (2008) Risk factors associated with neuroendocrine tumors: a U.S.-based case-control study. Int J Cancer 123:867–873

    Article  PubMed  CAS  Google Scholar 

  23. Chow WH, Linet MS, McLaughlin JK, Hsing AW, Chien HT, Blot WJ (1993) Risk factors for small intestine cancer. Cancer Causes Control 4:163–169

    Article  PubMed  CAS  Google Scholar 

  24. Qubaiah O, Devesa SS, Platz CE, Huycke MM, Dores GM (2010) Small intestinal cancer: a population-based study of incidence and survival patterns in the United States, 1992 to 2006. Cancer Epidemiol Biomarkers Prev 19:1908–1918

    Article  PubMed  Google Scholar 

  25. Chlebowski RT, Wactawski-Wende J, Ritenbaugh C, Hubbell FA, Ascensao J, Rodabough RJ, Rosenberg CA, Taylor VM, Harris R, Chen C, Adams-Campbell LL, White E (2004) Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med 350:991–1004

    Article  PubMed  CAS  Google Scholar 

  26. Green J, Czanner G, Reeves G, Watson J, Wise L, Roddam A, Beral V (2012) Menopausal hormone therapy and risk of gastrointestinal cancer: nested case-control study within a prospective cohort, and meta-analysis. Int J Cancer 130:2387–2396

    Google Scholar 

  27. Grodstein F, Newcomb PA, Stampfer MJ (1999) Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis. Am J Med 106:574–582

    Article  PubMed  CAS  Google Scholar 

  28. WCRF/AICR (2011) World Cancer Research Fund/American Institute for Cancer Research. Continuous Update Project. Food, Nutrition, Physical Activity, and the Prevention of Colorectal Cancer. Washington, DC

  29. Hassan MM, Phan A, Li D, Dagohoy CG, Leary C, Yao JC (2008) Family history of cancer and associated risk of developing neuroendocrine tumors: a case-control study. Cancer Epidemiol Biomarkers Prev 17:959–965

    Article  PubMed  Google Scholar 

  30. Sellner F (1990) Investigations on the significance of the adenoma-carcinoma sequence in the small bowel. Cancer 66:702–715

    Article  PubMed  CAS  Google Scholar 

  31. Kahi CJ, Rex DK, Imperiale TF (2008) Screening, surveillance, and primary prevention for colorectal cancer: a review of the recent literature. Gastroenterology 135:380–399

    Article  PubMed  Google Scholar 

  32. Neugut AI, Jacobson JS, Suh S, Mukherjee R, Arber N (1998) The epidemiology of cancer of the small bowel. Cancer Epidemiol Biomarkers Prev 7:243–251

    PubMed  CAS  Google Scholar 

  33. Babovic-Vuksanovic D, Constantinou CL, Rubin J, Rowland CM, Schaid DJ, Karnes PS (1999) Familial occurrence of carcinoid tumors and association with other malignant neoplasms. Cancer Epidemiol Biomarkers Prev 8:715–719

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors would like to acknowledge Dr. Arthur Schatzkin who was the principal investigator of the NIH-AARP Diet and Health study and tragically passed away on January 20, 2011. Cancer incidence data from the Atlanta metropolitan area were collected by the Georgia Center for Cancer Statistics, Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia. Cancer incidence data from California were collected by the California Cancer Registry, California Department of Public Health’s Cancer Surveillance and Research Branch, Sacramento, California. Cancer incidence data from the Detroit metropolitan area were collected by the Michigan Cancer Surveillance Program, Community Health Administration, Lansing, Michigan. The Florida cancer incidence data used in this report were collected by the Florida Cancer Data System (Miami, Florida) under contract with the Florida Department of Health, Tallahassee, Florida. The views expressed herein are solely those of the authors and do not necessarily reflect those of the FCDC or FDOH. Cancer incidence data from Louisiana were collected by the Louisiana Tumor Registry, Louisiana State University Health Sciences Center School of Public Health, New Orleans, Louisiana. Cancer incidence data from New Jersey were collected by the New Jersey State Cancer Registry, Cancer Epidemiology Services, New Jersey State Department of Health, Trenton, New Jersey. Cancer incidence data from North Carolina were collected by the North Carolina Central Cancer Registry, Raleigh, North Carolina. Cancer incidence data from Pennsylvania were supplied by the Division of Health Statistics and Research, Pennsylvania Department of Health, Harrisburg, Pennsylvania. The Pennsylvania Department of Health specifically disclaims responsibility for any analyses, interpretations, or conclusions. Cancer incidence data from Arizona were collected by the Arizona Cancer Registry, Division of Public Health Services, Arizona Department of Health Services, Phoenix, Arizona. Cancer incidence data from Texas were collected by the Texas Cancer Registry, Cancer Epidemiology and Surveillance Branch, Texas Department of State Health Services, Austin, Texas. Cancer incidence data from Nevada were collected by the Nevada Central Cancer Registry, State Health Division, State of Nevada Department of Health and Human Services, Las Vegas, Nevada. We are indebted to the participants in the NIH-AARP Diet and Health Study for their outstanding cooperation. We also thank Sigurd Hermansen and Kerry Grace Morrissey from Westat for study outcomes ascertainment and management, in addition to Leslie Carroll and Adam Risch at Information Management Services for data support and analysis. This work was supported by the Intramural Research Program of the National Cancer Institute, National Institutes of Health, Department of Health and Human Services.

Conflicts of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Amanda J. Cross.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cross, A.J., Hollenbeck, A.R. & Park, Y. A large prospective study of risk factors for adenocarcinomas and malignant carcinoid tumors of the small intestine. Cancer Causes Control 24, 1737–1746 (2013). https://doi.org/10.1007/s10552-013-0251-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10552-013-0251-8

Keywords

Navigation